A review of the public sector substance use disorder treatment and prevention systems in Kenya.


Journal

Substance abuse treatment, prevention, and policy
ISSN: 1747-597X
Titre abrégé: Subst Abuse Treat Prev Policy
Pays: England
ID NLM: 101258060

Informations de publication

Date de publication:
20 07 2020
Historique:
received: 01 05 2020
accepted: 14 07 2020
entrez: 22 7 2020
pubmed: 22 7 2020
medline: 2 9 2021
Statut: epublish

Résumé

The burden of substance use disorders in sub-Saharan Africa has been projected to increase by an estimated 130% by 2050. Despite this, little is known about the substance use disorder treatment and prevention systems in the region. The objective of this review is to describe the public sector substance use disorder treatment and prevention systems in Kenya guided by the World Health Organization health systems framework model, with the aim of informing decision-making. We reviewed official government documents obtained from hand-searching the websites of relevant governmental organizations including: Ministry of Health, National Authority for the Campaign Against Alcohol and Drug Abuse, Parliament of Kenya, Ministry of Treasury & National Planning, National Law Reporting Council, Kenya National Bureau of Statistics, the National Non-Governmental Organization (NGO) Coordination Board and the 47 County Governments. We augmented those searches with official documents that the authors were aware of by virtue of being practitioners in the field. Draft and retired documents were excluded. The findings of the search are presented as a narrative review. The Mental Health Act 1989, the main legislative framework governing substance use disorder treatment and prevention, focuses on institutional care only. While there are only three public health facilities offering substance use disorder treatment in Kenya, several non-public sector actors are involved in SUD treatment and prevention activities. Unfortunately, there is limited cross-sector collaboration. The Ministry of Health has no specific budget for substance use disorder treatment and prevention, while the National Authority for the Campaign Against Alcohol and Drug Abuse has an annual resource gap of about US$ 5,000,000. The substance use disorder workforce in Kenya has not been characterized. We propose five key strategies for strengthening substance use disorder treatment and prevention systems in Kenya including: (1) Enactment of the Mental Health (Amendment) bill 2018. (2) Integration of substance use disorder treatment and prevention into primary health care to increase access to care. (3) Utilization of money from taxation of alcohol, tobacco and betting to increase funding for substance use disorder treatment and prevention. (4) Characterization of the substance use disorder workforce to inform planning. (5) Enhanced collaboration between the government and non-state actors in order to increase access to SUD treatment and prevention.

Sections du résumé

BACKGROUND
The burden of substance use disorders in sub-Saharan Africa has been projected to increase by an estimated 130% by 2050. Despite this, little is known about the substance use disorder treatment and prevention systems in the region.
OBJECTIVES
The objective of this review is to describe the public sector substance use disorder treatment and prevention systems in Kenya guided by the World Health Organization health systems framework model, with the aim of informing decision-making.
METHODS
We reviewed official government documents obtained from hand-searching the websites of relevant governmental organizations including: Ministry of Health, National Authority for the Campaign Against Alcohol and Drug Abuse, Parliament of Kenya, Ministry of Treasury & National Planning, National Law Reporting Council, Kenya National Bureau of Statistics, the National Non-Governmental Organization (NGO) Coordination Board and the 47 County Governments. We augmented those searches with official documents that the authors were aware of by virtue of being practitioners in the field. Draft and retired documents were excluded. The findings of the search are presented as a narrative review.
DISCUSSION
The Mental Health Act 1989, the main legislative framework governing substance use disorder treatment and prevention, focuses on institutional care only. While there are only three public health facilities offering substance use disorder treatment in Kenya, several non-public sector actors are involved in SUD treatment and prevention activities. Unfortunately, there is limited cross-sector collaboration. The Ministry of Health has no specific budget for substance use disorder treatment and prevention, while the National Authority for the Campaign Against Alcohol and Drug Abuse has an annual resource gap of about US$ 5,000,000. The substance use disorder workforce in Kenya has not been characterized.
CONCLUSION
We propose five key strategies for strengthening substance use disorder treatment and prevention systems in Kenya including: (1) Enactment of the Mental Health (Amendment) bill 2018. (2) Integration of substance use disorder treatment and prevention into primary health care to increase access to care. (3) Utilization of money from taxation of alcohol, tobacco and betting to increase funding for substance use disorder treatment and prevention. (4) Characterization of the substance use disorder workforce to inform planning. (5) Enhanced collaboration between the government and non-state actors in order to increase access to SUD treatment and prevention.

Identifiants

pubmed: 32690036
doi: 10.1186/s13011-020-00291-5
pii: 10.1186/s13011-020-00291-5
pmc: PMC7372891
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

47

Références

Alcohol Res Health. 2011;33(4):350-5
pubmed: 23580019
Soc Sci Med. 2018 Mar;201:71-79
pubmed: 29455053
Lancet. 2009 Jun 27;373(9682):2223-33
pubmed: 19560604
Glob Health Action. 2014 Jul 31;7:24859
pubmed: 25084834
J Psychiatry Neurosci. 2013 Jul;38(4):219-21
pubmed: 23791139
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
PLoS One. 2014 Mar 20;9(3):e90297
pubmed: 24651115
Subst Abuse Treat Prev Policy. 2019 Jan 18;14(1):4
pubmed: 30658659
Ann Glob Health. 2014 Mar-Apr;80(2):115-21
pubmed: 24976549
Lancet. 2009 Jun 27;373(9682):2234-46
pubmed: 19560605
Int J Ment Health Addict. 2010 Oct;8(4):608-615
pubmed: 21037947
PLoS One. 2014 Oct 13;9(10):e110208
pubmed: 25310010
Health Policy Plan. 2018 Sep 1;33(7):777-785
pubmed: 29905855
Lancet Psychiatry. 2016 Mar;3(3):251-64
pubmed: 26905480

Auteurs

Florence Jaguga (F)

Moi Teaching & Referral Hospital, P.O. BOX 3-30100, Eldoret, Kenya. flokemboi@gmail.com.

Edith Kwobah (E)

Moi Teaching & Referral Hospital, P.O. BOX 3-30100, Eldoret, Kenya.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH